AimWe evaluated the associations of age and duration of type 2 diabetes with major diabetes-related complications.MethodsWe included 1.1 million people with type 2 diabetes from the Australian diabetes registry, followed from 2010 to 2019. We estimated the incidence of hospitalization or death from myocardial infarction (MI), stroke, and heart failure (HF), and hospitalisation for lower extremity amputation (LEA); end-stage kidney disease (ESKD; kidney replacement therapy or death from ESKD); and all-cause mortality. Poisson regression was used to model incidence by attained age, age at diabetes diagnosis, and duration of diabetes.ResultsRisk for complications increased exponentially with diabetes duration. Effects of attained age differed ...
OBJECTIVE — To determine whether adults diagnosed with type 2 diabetes from age 18 to 44 years more ...
Objectives: To examine the association between type 2 diabetes mellitus, with and without diabetic n...
OBJECTIVEdTo evaluate long-term clinical outcomes and survival in young-onset type 2 diabetes (T2DM)...
AimWe evaluated the associations of age and duration of type 2 diabetes with major diabetes-related ...
Background Type 2 diabetes (T2DM) is increasingly diagnosed in younger patients. The trajectory of c...
Aims To determine absolute and relative risks of all-cause and cardiovascular mortality among patien...
OBJECTIVE — The risk of coronary heart disease (CHD) in type 2 diabetes is two- to three-fold higher...
Aim To predict mortality risk and life expectancy for patients with Type 2 diabetes after a major di...
[[abstract]]Aim: To compare long-term outcomes among three groups with different ages of diabetes on...
Aims: To compare the prevalence and risk of diabetic complications between people with young-onset a...
BACKGROUND: The natural history of type 2 diabetes mellitus (DM) in the elderly has not been previou...
Objective In this study, we examined trends in severe diabetes-related complications (acute myocardi...
Aims/hypothesis: Few studies examine the association between age at diagnosis and subsequent complic...
Background. Several studies have reported differences in the mortality risk between diabetic subject...
Background The prevalence of type 2 diabetes is increasing rapidly, particularly among younger age g...
OBJECTIVE — To determine whether adults diagnosed with type 2 diabetes from age 18 to 44 years more ...
Objectives: To examine the association between type 2 diabetes mellitus, with and without diabetic n...
OBJECTIVEdTo evaluate long-term clinical outcomes and survival in young-onset type 2 diabetes (T2DM)...
AimWe evaluated the associations of age and duration of type 2 diabetes with major diabetes-related ...
Background Type 2 diabetes (T2DM) is increasingly diagnosed in younger patients. The trajectory of c...
Aims To determine absolute and relative risks of all-cause and cardiovascular mortality among patien...
OBJECTIVE — The risk of coronary heart disease (CHD) in type 2 diabetes is two- to three-fold higher...
Aim To predict mortality risk and life expectancy for patients with Type 2 diabetes after a major di...
[[abstract]]Aim: To compare long-term outcomes among three groups with different ages of diabetes on...
Aims: To compare the prevalence and risk of diabetic complications between people with young-onset a...
BACKGROUND: The natural history of type 2 diabetes mellitus (DM) in the elderly has not been previou...
Objective In this study, we examined trends in severe diabetes-related complications (acute myocardi...
Aims/hypothesis: Few studies examine the association between age at diagnosis and subsequent complic...
Background. Several studies have reported differences in the mortality risk between diabetic subject...
Background The prevalence of type 2 diabetes is increasing rapidly, particularly among younger age g...
OBJECTIVE — To determine whether adults diagnosed with type 2 diabetes from age 18 to 44 years more ...
Objectives: To examine the association between type 2 diabetes mellitus, with and without diabetic n...
OBJECTIVEdTo evaluate long-term clinical outcomes and survival in young-onset type 2 diabetes (T2DM)...